Lori Daniels

Lori Daniels is a Clinical Professor in the Department of Family Medicine and Public Health at the University of California, San Diego (UCSD), specializing in cardiovascular epidemiology and biomarker research. She holds academic appointments within the School of Medicine and leads research initiatives in critical care cardiology, Kawasaki disease sequelae, and biomarker-driven clinical decision-making.

Education:

• MD from Harvard Medical School
• Internal Medicine Residency and Cardiovascular Fellowship at UCSD
• Advanced Clinical Studies (MAS) at UCSD

Research Interests:

Dr. Daniels focuses on cardiovascular biomarkers (BNP, troponin, galectin-3), critical care outcomes in cardiac intensive care units (CICUs), and long-term cardiovascular sequelae of Kawasaki disease. Her work emphasizes improving diagnostic accuracy, risk stratification, and patient management through multi-marker approaches and large-scale registry data.

Key Contributions:

• Founded and leads the Critical Care Cardiology Trials Network (CCCTN), a multicenter registry analyzing CICU practices and outcomes.
• Pioneered studies on breast arterial calcification as an independent cardiovascular risk factor in women.
• Advanced understanding of statin and anti-hypertensive therapies in acute conditions like COVID-19.

Awards & Recognition:

• Consistently honored as "America's Top Doctor" (Castle Connolly, 2011–2022)
• Recipient of multiple teaching awards from UCSD Graduating Housestaff
• American College of Cardiology 2010 Emerging Faculty Award

Grants & Collaborations:

Active funding includes NIH grants for Kawasaki disease longitudinal studies and AHA awards for CCCTN registry analyses. Collaborates with institutions like Harvard, USC, and international centers.